company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q1,2011-01-01,2011-03-31,2012-06-08 16:47:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11049000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q1,2011-01-01,2011-03-31,2012-06-08 16:47:34+00:00,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,-1334000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q1,2011-01-01,2011-03-31,2012-06-08 16:47:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9715000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q1,2011-01-01,2011-03-31,2012-06-08 16:47:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,208000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q1,2011-01-01,2011-03-31,2012-06-08 16:47:34+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,39000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q1,2011-01-01,2011-03-31,2012-06-08 16:47:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-163000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q1,2011-01-01,2011-03-31,2012-06-08 16:47:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1919000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q1,2011-01-01,2011-03-31,2012-06-08 16:47:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11550000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q1,2011-01-01,2011-03-31,2012-06-08 16:47:34+00:00,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,1749000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q1,2011-01-01,2011-03-31,2012-06-08 16:47:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9801000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q1,2011-01-01,2011-03-31,2012-06-08 16:47:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-203000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q1,2011-01-01,2011-03-31,2012-06-08 16:47:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-13848000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q1,2011-01-01,2011-03-31,2012-06-08 16:47:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8349000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q1,2011-01-01,2011-03-31,2012-06-08 16:47:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5702000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q1,2011-01-01,2011-03-31,2012-06-08 16:47:34+00:00,netcashfrominvestingactivities,netcashfromdiscontinuedinvestingactivities,Net Cash From Discontinued Investing Activities,+,debit,usd,0.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q1,2011-01-01,2011-03-31,2012-06-08 16:47:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5702000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q1,2011-01-01,2011-03-31,2012-06-08 16:47:34+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-656000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q1,2011-01-01,2011-03-31,2012-06-08 16:47:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q1,2011-01-01,2011-03-31,2012-06-08 16:47:34+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,15000000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q1,2011-01-01,2011-03-31,2012-06-08 16:47:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,14344000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q1,2011-01-01,2011-03-31,2012-06-08 16:47:34+00:00,netcashfromfinancingactivities,netcashfromdiscontinuedfinancingactivities,Net Cash From Discontinued Financing Activities,+,debit,usd,-1739000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q1,2011-01-01,2011-03-31,2012-06-08 16:47:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,12605000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q1,2011-01-01,2011-03-31,2012-06-08 16:47:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2898000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q1,2011-01-01,2011-03-31,2012-06-08 16:47:34+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,165000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7377000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,1563000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8940000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,219000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,60000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,46000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,506000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8109000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-915000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9024000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-213000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4042000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8086000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3831000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3831000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-14000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,15000000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-15000000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-13000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromdiscontinuedfinancingactivities,Net Cash From Discontinued Financing Activities,+,debit,usd,925000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,912000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4281000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q2,2011-04-01,2011-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,6582000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9734000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,417000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10151000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,224000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,60000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,49000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-591000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10409000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,1307000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9102000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-78000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10420000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10342000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10342000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-35000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-35000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromdiscontinuedfinancingactivities,Net Cash From Discontinued Financing Activities,+,debit,usd,-1282000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1317000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-77000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q3,2011-07-01,2011-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3287000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,81975000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,76394000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5581000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,228000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,59000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-16283000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2277000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8138000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-120000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8258000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-191000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-176000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromdiscontinuedinvestingactivities,Net Cash From Discontinued Investing Activities,+,debit,usd,25607000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,25431000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-270000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-15000000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,28000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,30000000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,14758000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromdiscontinuedfinancingactivities,Net Cash From Discontinued Financing Activities,+,debit,usd,129000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,14887000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,32060000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-8622000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10011000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19288000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9599000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9689000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9689000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-120000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-15018000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7381000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-21553000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-29310000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-29310000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3537000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,52359000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1057000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,47765000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,47765000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,22610000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,31376000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,2012-04-01,2012-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,800000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13483000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13483000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,212000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,84000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,95000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1790000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11302000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11302000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-393000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19652000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9742000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10303000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10303000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2264000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,39000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2225000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2225000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-23830000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,2012-07-01,2012-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,769000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13513000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13513000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,221000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,82000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,180000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3110000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16140000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16140000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-200000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-41198000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,32052000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9346000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9346000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5912000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,48288000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,42376000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,42376000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16890000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,681000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27357000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-45771000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,30016000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15755000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15755000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-665000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-45361000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11547000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3149000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-37628000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-37628000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-24985000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,90000000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,217000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1021000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,64211000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,64211000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,4170000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,14998000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,2013-04-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,365000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24096000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24096000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,200000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1183000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,645000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6518000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15550000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15550000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-377000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-306000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-17964000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,23253000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4606000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4606000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-29000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,11000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-18000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-18000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10962000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22406000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22406000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,216000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,963000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,17005000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5199000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9421000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9421000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-232000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-399000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6599000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,28140000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,20910000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,20910000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1727000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,273000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1454000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1454000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,10035000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,3338000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:27:39+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15543000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:27:39+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15543000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:27:39+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,227000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:27:39+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,574000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:27:39+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2361000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:27:39+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6723000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:27:39+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19104000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:27:39+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19104000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:27:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-263000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:27:39+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1056000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:27:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9406000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:27:39+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9096000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:27:39+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1629000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:27:39+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1629000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:27:39+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:27:39+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:27:39+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:27:39+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 17:27:39+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-20728000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3201000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3201000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,233000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,513000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,691000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11578000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6940000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6940000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-118000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-984000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10496000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17997000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6399000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6399000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,245000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,245000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,245000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-296000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,2014-04-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1502000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2371000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2371000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,241000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,512000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6111000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9207000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4714000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4714000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-94000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,2040000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-14664000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14894000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1652000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,524000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,524000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,1000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,14000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,30000000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,30016000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,30014000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,25824000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3788000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3788000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,227000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,491000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3618000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1861000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6263000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6263000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-118000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2277000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-18696000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11486000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1652000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7953000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7953000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,304000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,306000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1384000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1352000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,2015-01-01,2015-03-31,2017-01-20 17:28:15+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,738000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,2015-01-01,2015-03-31,2017-01-20 17:28:15+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,738000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,2015-01-01,2015-03-31,2017-01-20 17:28:15+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,214000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,2015-01-01,2015-03-31,2017-01-20 17:28:15+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5158000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,2015-01-01,2015-03-31,2017-01-20 17:28:15+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6375000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,2015-01-01,2015-03-31,2017-01-20 17:28:15+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-265000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,2015-01-01,2015-03-31,2017-01-20 17:28:15+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-265000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,2015-01-01,2015-03-31,2017-01-20 17:28:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-189000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,2015-01-01,2015-03-31,2017-01-20 17:28:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-17967000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,2015-01-01,2015-03-31,2017-01-20 17:28:15+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8731000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,2015-01-01,2015-03-31,2017-01-20 17:28:15+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1695000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,2015-01-01,2015-03-31,2017-01-20 17:28:15+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11120000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,2015-01-01,2015-03-31,2017-01-20 17:28:15+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11120000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,2015-01-01,2015-03-31,2017-01-20 17:28:15+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,147000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,2015-01-01,2015-03-31,2017-01-20 17:28:15+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,147000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,2015-01-01,2015-03-31,2017-01-20 17:28:15+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,147000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,2015-01-01,2015-03-31,2017-01-20 17:28:15+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11238000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2438000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2438000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,217000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7451000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2871000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,12977000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,12977000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-588000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-16960000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13131000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2123000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6540000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6540000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,862000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,862000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,862000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7299000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,2015-04-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,504000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3916000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3916000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,220000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,646000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3731000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6628000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1885000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1885000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-463000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-17015000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11809000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3090000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8759000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8759000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,58000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,58000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,58000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6816000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6852000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6852000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,270000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,102000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8924000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3779000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,19927000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,19927000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-864000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-10907000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-11917000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3910000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,6908000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12870000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12870000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,800000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,800000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,800000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7857000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,321000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,2016-01-01,2016-03-31,2017-01-20 17:28:15+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4825000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,2016-01-01,2016-03-31,2017-01-20 17:28:15+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4825000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,2016-01-01,2016-03-31,2017-01-20 17:28:15+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,429000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,2016-01-01,2016-03-31,2017-01-20 17:28:15+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3959000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,2016-01-01,2016-03-31,2017-01-20 17:28:15+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12355000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,2016-01-01,2016-03-31,2017-01-20 17:28:15+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3142000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,2016-01-01,2016-03-31,2017-01-20 17:28:15+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3142000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,2016-01-01,2016-03-31,2017-01-20 17:28:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-279000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,2016-01-01,2016-03-31,2017-01-20 17:28:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-17335000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,2016-01-01,2016-03-31,2017-01-20 17:28:15+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7400000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,2016-01-01,2016-03-31,2017-01-20 17:28:15+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-436000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,2016-01-01,2016-03-31,2017-01-20 17:28:15+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10650000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,2016-01-01,2016-03-31,2017-01-20 17:28:15+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10650000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,2016-01-01,2016-03-31,2017-01-20 17:28:15+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,124000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,2016-01-01,2016-03-31,2017-01-20 17:28:15+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,124000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,2016-01-01,2016-03-31,2017-01-20 17:28:15+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,124000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,2016-01-01,2016-03-31,2017-01-20 17:28:15+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13668000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,10251000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10251000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,688000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8260000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2422000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,16777000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,16777000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-624000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5704000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8258000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3252000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1322000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1322000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,871000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,871000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,871000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16326000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,2016-04-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,247000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,61826000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,61826000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,611000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,226000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5903000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-40327000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,28239000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,28239000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-399000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-12224000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8155000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6740000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,3688000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10350000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10350000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,260000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,260000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,260000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,18149000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 13:57:37+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,10297000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 13:57:37+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10297000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 13:57:37+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,741000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 13:57:37+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-313000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 13:57:37+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3245000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 13:57:37+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-612000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 13:57:37+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,13358000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 13:57:37+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,13358000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 13:57:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-300000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 13:57:37+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-3408000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 13:57:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-22193000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 13:57:37+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5140000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 13:57:37+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-20761000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 13:57:37+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-20761000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 13:57:37+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,604000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 13:57:37+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,604000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 13:57:37+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,604000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 13:57:37+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6799000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,17368000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,17368000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1343000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,36000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5515000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1680000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,25942000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,25942000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-552000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-5816000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-26275000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7279000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-25364000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-25364000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1560000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1560000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1560000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2138000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,2017-04-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,134000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,2017-04-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1710000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,15961000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15961000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4378000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-15000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13377000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5304000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,39005000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,39005000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-421000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-906000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-30470000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10633000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-21164000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-21164000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2346000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2346000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2346000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,20187000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,2017-07-01,2017-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,426000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,13658000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13658000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1670000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-221000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9142000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,12086000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,36335000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,36335000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-756000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1024000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-22951000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5605000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-19126000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-19126000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1171000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1171000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1171000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,18380000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q4,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-548000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:38:41+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,26352000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:38:41+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26352000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:38:41+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1707000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:38:41+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,701000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:38:41+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6727000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:38:41+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8354000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:38:41+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,27133000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:38:41+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,27133000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:38:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-253000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:38:41+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-343000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:38:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-57757000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:38:41+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7343000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:38:41+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-51010000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:38:41+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-51010000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:38:41+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-10435000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:38:41+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,402500000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:38:41+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,68545000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:38:41+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-92897000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:38:41+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,367713000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:38:41+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,367713000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:38:41+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,343836000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 15:38:41+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,5623000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,30737000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,30737000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1780000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1764000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-218000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-27534000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6529000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6556000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-304000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-58000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-433898000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12123000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-422137000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-422137000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6646000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6646000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6646000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-408935000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,2018-04-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,23656000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,28011000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,28011000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1884000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3762000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,18214000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,10604000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,62475000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,62448000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-191000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-278000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,1000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25805000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,25337000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,25337000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,828000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,828000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,828000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,88613000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,2018-07-01,2018-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,651000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,25893000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,25893000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1692000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3956000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,23645000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-22337000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,32849000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,32849000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-96000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-130000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,34556000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,34330000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,34330000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1251000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1251000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1251000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,68430000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1342000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q4,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4842000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,2019-01-01,2019-03-31,2020-05-15 16:28:01+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,18340000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,2019-01-01,2019-03-31,2020-05-15 16:28:01+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18340000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,2019-01-01,2019-03-31,2020-05-15 16:28:01+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1679000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,2019-01-01,2019-03-31,2020-05-15 16:28:01+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2746000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,2019-01-01,2019-03-31,2020-05-15 16:28:01+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-14836000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,2019-01-01,2019-03-31,2020-05-15 16:28:01+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,25064000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,2019-01-01,2019-03-31,2020-05-15 16:28:01+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,32993000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,2019-01-01,2019-03-31,2020-05-15 16:28:01+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,32993000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,2019-01-01,2019-03-31,2020-05-15 16:28:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-221000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,2019-01-01,2019-03-31,2020-05-15 16:28:01+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,2019-01-01,2019-03-31,2020-05-15 16:28:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-150167000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,2019-01-01,2019-03-31,2020-05-15 16:28:01+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,47143000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,2019-01-01,2019-03-31,2020-05-15 16:28:01+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-103246000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,2019-01-01,2019-03-31,2020-05-15 16:28:01+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-103246000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,2019-01-01,2019-03-31,2020-05-15 16:28:01+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,783000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,2019-01-01,2019-03-31,2020-05-15 16:28:01+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,783000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,2019-01-01,2019-03-31,2020-05-15 16:28:01+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,783000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,2019-01-01,2019-03-31,2020-05-15 16:28:01+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-69470000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,2019-01-01,2019-03-31,2020-05-15 16:28:01+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,1258000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,2019-01-01,2019-03-31,2020-05-15 16:28:01+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,800000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,32727000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,32727000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1676000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,4559000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10374000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-20729000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,28607000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,28687000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-24000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-114759000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,49022000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-65761000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-65761000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1640000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1640000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1640000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-35434000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,2019-04-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,23995000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,28860000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,28860000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1674000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1207000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8575000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2578000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,37738000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,37658000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-462000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-96195000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,88302000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8355000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8355000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,242000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,242000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,242000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,29545000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,2019-07-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1258000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,2019-07-01,2019-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,11138000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,33129000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,33129000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1630000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2861000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13713000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7542000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,43791000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,43791000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2029000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,1000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-48586000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1349000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,68703000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,19438000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,19438000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1263000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1263000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1263000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,64492000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q4,2019-10-01,2019-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,15607000.0
